Ayurvedic drug to cure Type II diabetes without side effects
“We have developed a medicine for Type-II diabetes patients on Ayurvedic method, which does not have any side effect,” Senior Principal Scientist A K S Rawat told PTI today.
Generally antigens affect body organs on the long run. But this drug contains anti-oxidants, which help in rebuilding process, he said.
Rawat said the initiative was taken by NBRI Director C S Nautiyal.
He said the drug has been introduced in tablet form. The Ayurvedic drug has been named ‘BGR-34’ and may cost Rs 500 for 100 tablets.
“If taken for a longer period, it may also reduce dependence on insulin,” Rawat said.
A combination of natural extracts, the drug has been jointly developed by two CSIR laboratories — NBRI and the Central Institute for Medicinal and Aromatic Plant (CIMAP) — both in Lucknow.
NBRI has given permission to a Delhi-based pharmaceutical firm for commercial manufacturing and marketing of the medicine.
“The drug has extracts from four plants mentioned in Ayurveda and that makes it safe,” Rawat said.
He said tests carried on animals and related scientific study found it to be safe and effective with clinical trials showing 67 per cent success.
Rawat said the drug improves immune system and works as an antioxidant.
“Normally persistent use of antibiotics affect kidney, liver and heart, but this is not the case with this herbal drug,” he said.
Though there are other anti-diabetic herbal drugs in the market, BGR-34 has been validated scientifically.
The drug will help maintain normal blood glucose levels, reduce chances of complications due to persistent high blood glucose levels and impart a good quality life to patients with high blood sugar levels.
Rawat said diabetes mellitus was a complex metabolic disorder resulting from either insulin insufficiency or insulin dysfunction.
Type-II diabetes is the more common form of diabetes accounting for 90 per cent of the diabetic population.
The prevalence of diabetes has increased ten-fold between 1971 and 2000.
“It is estimated that 61.3 million people aged 20-79 years live with diabetes in India (2011 estimates). This number is expected to increase to 101.2 million by 2030. 77.2 million people in India are said to have pre-diabetes,” Rawat said.
Therefore, considering the prevalence and emergence of herbal drugs based on traditional knowledge, CSIR-National Botanical research Institute and CSIR-Central Institute of Medicinal and Aromatic Plants developed a scientifically validated herbal combination for management of diabetes conditions, he added.
Image: Getty Images